Institutional Ownership Achilles Therapeutics PLC (ACHL)
This table provides information about the institutional ownership of Achilles Therapeutics PLC (ACHL). We have compiled data on the 3 institutions that hold shares in the stock, with a total of 7,286 shares, which have been reported (via 13F filing form) to have a value of $10,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
4,480
shares
|
$6,630
0.0% of portfolio
|
Q2 2024
Added 27.49%
|
|
|
Endurance Wealth Management, Inc.
|
Aug 09, 2023 Q2 2023 |
2,000
shares
|
$2,960
0.0% of portfolio
|
Q1 2023
Added 99900.0%
|
|
|
Gamma Investing LLC
Foster City, CA |
Jul 14, 2025 Q2 2025 |
806
shares
|
$1,192
0.0% of portfolio
|
Q1 2025
Reduced 32.44%
|